funder-graph

FundersFL

Grants paid by Phelan Mcdermid Syndrome Foundation

EIN 04-3673104 · Osprey, FL · Form 990, Schedule I · NTEE H80

Phelan Mcdermid Syndrome Foundation of Osprey, FL (EIN 04-3673104) reported 10 grants paid totaling $623,980 to 8 recipients in tax years 2021–2025, on Form 990, Schedule I. Derived from IRS e-file data, dataset version 2026.09.0, built 2026-09-03.

Grants paid

$623,980

10 grants

Recipients

8

distinct organizations

Tax years

2021–2025

5 filings in the corpus

By tax year

Grants by tax year, as the same figures
Tax yearGrants paidAmount paidApproved for future
20211$11,688
20221$20,900
20234$220,000
20243$271,392
20251$100,000

Top recipients

The 8 recipients receiving the most from Phelan Mcdermid Syndrome Foundation, by grants paid, out of 8 distinct recipients.

Recipients ranked by total grants paid
RecipientMatchLocationGrantsTotal paidLatest year
Boston Children's Hospital Children's Hospital Corporation 04-2774441ABoston, MA2$216,3922024
Seaver Autism Center Icahn School of Medicine at Mount Sinai 13-6171197ANew York, NY2$120,9002024
Children's Hospital of Los Angeles 95-1690977ALos Angeles, CA1$100,0002025
University of Miami 59-0624458ACoral Gables, FL1$55,0002023
Clemson University Foundation 57-0426335AClemson, SC1$55,0002023
Northeastern University 04-1679980ABoston, MA1$55,0002024
Kyle's Angels 85-1554186ASaint Robert, MO1$11,6882021
Autism Science Foundation 26-4522309AScarsdale, NY1$10,0002023

Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.

Every grant

All 10 grant rows this organization reported, most recent first.

Grants reported by Phelan Mcdermid Syndrome Foundation
Tax yearRecipientMatchAmountTypePurposeSource filing
2025Children's Hospital of Los Angeles Los Angeles, CAA$100,000paidTo identify diagnostic biomarkers in up to 30 individuals with Phelan-McDermid syndrome who present with neuropsychiatric disease. To determine whether these individuals exhibit distinct cytokine, proteomic, and metabolomic profiles in the serum and cerebrospinal fluid indicative of systemic and/or central inflammation. To evaluate markers of cortical and white matter disruption using magnetic resonance imaging and electroencephalography.202630699349300018
2024Boston Children's Hospital Children's Hospital Corporation Boston, MAA$116,392paidTo support the conclusion of the second phase of the Developmental Synaptopathies Consortium's Phelan-McDermid syndrome natural history study, including Boston Children's Hospital personnel costs and subawards to Icahn Mount Sinai Medical Center and Rush University for personnel costs as well.202510729349300041
2024Seaver Autism Center Icahn School of Medicine at Mount Sinai New York, NYA$100,000paidTo fund the further development of the Phelan-McDermid syndrome Inventory for Psychiatric Symptoms (PIPS) tool, to better support individuals with Phelan McDermid syndrome and their caregivers with managing and intervening in neuropsychiatric episodes experienced by these individuals.202510729349300041
2024Northeastern University Boston, MAA$55,000paidTo support a project seeking to expand a new natural communication sampling protocol called ROSCO (Rapid Online Sample of Communication). ROSCO is designed to elicit meaningful samples of communication from individuals with Phelan McDermid syndrome via online-video platforms like Zoom in approximately 15 minutes. This study will validate the ROSCO paradigm with the Phelan McDermid syndrome population longitudinally, using repeated samples to establish reliability and sensitivity to communication change over time.202510729349300041
2023Children's Hospital Corporation DBA Boston Children's Hospital Boston, MAA$100,000paidTo understand whether people with Phelan-McDermid syndrome, particularly those with severe neuropsychiatric illness (SNPI) -- have underlying differences in their immune system that might guide treatment.202440619349300914
2023Clemson University Foundation Clemson, SCA$55,000paidTo study the response of cells from individuals with Phelan-McDermid syndrome to candidate therapeutics/treatments (such as Insulin-like Growth Factor 1 and human growth hormone) and identify subgroups in the Phelan-McDermid syndrome population that will potentially respond better or worse to the selected compounds.202440619349300914
2023University of Miami Coral Gables, FLA$55,000paidTo develop an alternative objective measure of Gastrointestinal motility (GI transit) in individuals with Phelan-McDermid syndrome. Muffins with blue dye will be ingested by individuals with Phelan-McDermid syndrome and caregivers will use a mobile app to track and report GI transit time.202440619349300914
2023Autism Science Foundation Scarsdale, NYA$10,000paidTo model neuroinflammation and neuropsychiatric regression in profound autism.202440619349300914
2022Icahn School of Medicine at Mount Sinai New York, NYA$20,900paidTo define and retrospectively characterize the neurobehavioral profile of individuals with Phelan-McDermid syndrome and neuropsychiatric decompensation. To develop clinician and caregiver survey tools for qualitative assessment of clinical outcomes based on recommendations from the Phelan-McDermid syndrome Neuropsychiatric Consultation Group.202310699349301566
2021Kyle's Angels Saint Robert, MOA$11,688paidTo fund travel assistance for individuals with Phelan-McDermid Syndrome and their families to events hosted by the Phelan-McDermid Syndrome Foundation, most notably the biennial international family conference.202240689349300049

Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.

Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.

Source filings

Every figure above is traceable to one of these IRS e-file returns by its OBJECT_ID.

Returns this page is derived from
FormTax yearPeriod endFiledSchemaIRS OBJECT_ID
99020252025-12-31not stated2025v4.0202630699349300018
99020242024-12-31not stated2024v5.0202510729349300041
99020232023-12-31not stated2023v4.0202440619349300914
99020222022-12-31not stated2022v4.0202310699349301566
99020212021-12-31not stated2021v4.0202240689349300049

Derived from IRS Form 990 e-file XML; recipient identities from the IRS Exempt Organizations Business Master File. Dataset version 2026.09.0, built 2026-09-03. The same rows as Parquet: manifest; as JSON: /api/funders/043673104.json.

The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.

This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.